SG11201405958RA - Nicotine formulation - Google Patents
Nicotine formulationInfo
- Publication number
- SG11201405958RA SG11201405958RA SG11201405958RA SG11201405958RA SG11201405958RA SG 11201405958R A SG11201405958R A SG 11201405958RA SG 11201405958R A SG11201405958R A SG 11201405958RA SG 11201405958R A SG11201405958R A SG 11201405958RA SG 11201405958R A SG11201405958R A SG 11201405958RA
- Authority
- SG
- Singapore
- Prior art keywords
- nicotine formulation
- nicotine
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615997P | 2012-03-27 | 2012-03-27 | |
| EP12161483 | 2012-03-27 | ||
| PCT/EP2013/055456 WO2013143891A1 (en) | 2012-03-27 | 2013-03-15 | Nicotine formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201405958RA true SG11201405958RA (en) | 2014-10-30 |
Family
ID=49258262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405958RA SG11201405958RA (en) | 2012-03-27 | 2013-03-15 | Nicotine formulation |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20150096572A1 (ru) |
| EP (1) | EP2830589B1 (ru) |
| JP (2) | JP6412492B2 (ru) |
| KR (1) | KR102038342B1 (ru) |
| CN (1) | CN104411297B (ru) |
| AU (1) | AU2013242200B2 (ru) |
| BR (1) | BR112014023823B1 (ru) |
| CA (1) | CA2868445C (ru) |
| HK (1) | HK1205679A1 (ru) |
| IN (1) | IN2014DN08879A (ru) |
| MX (1) | MX362918B (ru) |
| MY (1) | MY183216A (ru) |
| NZ (1) | NZ626974A (ru) |
| PL (1) | PL2830589T3 (ru) |
| RS (1) | RS58677B1 (ru) |
| RU (1) | RU2625836C2 (ru) |
| SG (1) | SG11201405958RA (ru) |
| SI (1) | SI2830589T1 (ru) |
| UA (1) | UA116440C2 (ru) |
| WO (1) | WO2013143891A1 (ru) |
| ZA (1) | ZA201407677B (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3166563B1 (en) * | 2014-07-08 | 2020-12-16 | Fertin Pharma A/S | Oral delivery system comprising two compartments |
| US20200085806A1 (en) * | 2016-12-20 | 2020-03-19 | Fertin Pharma A/S | A mucoadhesive oromucosal formulation comprising a nicotine complex |
| BR112021009438A2 (pt) * | 2018-12-28 | 2021-08-17 | Philip Morris Products S.A. | formulação de nicotina compreendendo sal metálico |
| MX2021007624A (es) * | 2018-12-31 | 2021-08-11 | Philip Morris Products Sa | Formulacion de nicotina liquida. |
| SE544672C2 (en) * | 2020-05-07 | 2022-10-11 | Liw Innovation Ab | New compositions for oral or nasal use |
| WO2024037043A1 (zh) * | 2023-04-28 | 2024-02-22 | 深圳华宝协同创新技术研究院有限公司 | 用于口腔粘膜的包含尼古丁的薄膜组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86170A (en) | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
| CA2178021C (en) * | 1996-04-19 | 1999-09-28 | Theodore H. Stanley | Tobacco substitute |
| SE9900215D0 (sv) | 1999-01-26 | 1999-01-26 | Pharmacia & Upjohn Ab | New use |
| JP5089840B2 (ja) * | 2001-09-25 | 2012-12-05 | 救急薬品工業株式会社 | ニコチン含有フィルム製剤 |
| GB0508306D0 (en) * | 2005-04-25 | 2005-06-01 | Bioprogress Technology Ltd | Nicotine dosage forms |
| SE530184C2 (sv) * | 2005-12-23 | 2008-03-18 | Kjell Stenberg | Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater |
| US20080286340A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
| US20080286341A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
| CA2702222C (en) * | 2007-10-11 | 2016-08-30 | Richard Fuisz | Smokeless tobacco product |
| WO2009074552A2 (en) * | 2007-12-11 | 2009-06-18 | Novartis Ag | Multi-zone films |
| SI2405942T1 (en) * | 2009-03-13 | 2018-04-30 | Excellent Tech Products I Sverige Ab | Oral feed product |
-
2013
- 2013-03-15 NZ NZ626974A patent/NZ626974A/en unknown
- 2013-03-15 MY MYPI2014002725A patent/MY183216A/en unknown
- 2013-03-15 BR BR112014023823-5A patent/BR112014023823B1/pt active IP Right Grant
- 2013-03-15 CA CA2868445A patent/CA2868445C/en active Active
- 2013-03-15 AU AU2013242200A patent/AU2013242200B2/en active Active
- 2013-03-15 RS RS20190478A patent/RS58677B1/sr unknown
- 2013-03-15 PL PL13712730T patent/PL2830589T3/pl unknown
- 2013-03-15 CN CN201380017041.5A patent/CN104411297B/zh active Active
- 2013-03-15 SG SG11201405958RA patent/SG11201405958RA/en unknown
- 2013-03-15 US US14/386,083 patent/US20150096572A1/en not_active Abandoned
- 2013-03-15 RU RU2014143003A patent/RU2625836C2/ru active
- 2013-03-15 UA UAA201407757A patent/UA116440C2/uk unknown
- 2013-03-15 KR KR1020147023909A patent/KR102038342B1/ko active IP Right Grant
- 2013-03-15 JP JP2015502199A patent/JP6412492B2/ja active Active
- 2013-03-15 SI SI201331410T patent/SI2830589T1/sl unknown
- 2013-03-15 MX MX2014010760A patent/MX362918B/es active IP Right Grant
- 2013-03-15 EP EP13712730.4A patent/EP2830589B1/en active Active
- 2013-03-15 WO PCT/EP2013/055456 patent/WO2013143891A1/en active Application Filing
-
2014
- 2014-10-22 IN IN8879DEN2014 patent/IN2014DN08879A/en unknown
- 2014-10-22 ZA ZA2014/07677A patent/ZA201407677B/en unknown
-
2015
- 2015-06-30 HK HK15106184.6A patent/HK1205679A1/xx unknown
-
2017
- 2017-08-04 JP JP2017151485A patent/JP2017226686A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2868445C (en) | 2020-01-28 |
| US20150096572A1 (en) | 2015-04-09 |
| RU2625836C2 (ru) | 2017-07-19 |
| IN2014DN08879A (ru) | 2015-05-22 |
| HK1205679A1 (en) | 2015-12-24 |
| EP2830589B1 (en) | 2019-02-13 |
| JP6412492B2 (ja) | 2018-10-24 |
| MY183216A (en) | 2021-02-18 |
| UA116440C2 (uk) | 2018-03-26 |
| WO2013143891A1 (en) | 2013-10-03 |
| ZA201407677B (en) | 2016-05-25 |
| CN104411297A (zh) | 2015-03-11 |
| JP2015516948A (ja) | 2015-06-18 |
| CA2868445A1 (en) | 2013-10-03 |
| RS58677B1 (sr) | 2019-06-28 |
| BR112014023823A2 (ru) | 2017-06-20 |
| PL2830589T3 (pl) | 2019-07-31 |
| RU2014143003A (ru) | 2016-05-20 |
| MX362918B (es) | 2019-02-26 |
| KR102038342B1 (ko) | 2019-10-30 |
| CN104411297B (zh) | 2017-10-24 |
| SI2830589T1 (sl) | 2019-06-28 |
| JP2017226686A (ja) | 2017-12-28 |
| AU2013242200A1 (en) | 2014-10-16 |
| KR20140140021A (ko) | 2014-12-08 |
| AU2013242200B2 (en) | 2017-03-02 |
| EP2830589A1 (en) | 2015-02-04 |
| NZ626974A (en) | 2016-09-30 |
| BR112014023823B1 (pt) | 2022-04-26 |
| MX2014010760A (es) | 2015-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211188A1 (en) | Nicotine composition | |
| SI2877155T1 (sl) | Opioidne formulacije | |
| EP2932860A4 (en) | CIGARETTE | |
| HK1202445A1 (en) | New formulation | |
| ZA201306000B (en) | Stable formulation | |
| HK1205679A1 (en) | Nicotine formulation | |
| IL289157A (en) | Opioid compounds | |
| PL2908835T3 (pl) | Stabilne formulacje | |
| EP2856890A4 (en) | CIGARETTE | |
| EP2818060A4 (en) | CIGARETTE | |
| AU345796S (en) | Cigarette | |
| AU345797S (en) | Cigarette | |
| HK1207290A1 (en) | Oral formulation | |
| PL2908859T3 (pl) | Formulacje arypiprazolu | |
| IL234771B (en) | Nicotine formulation | |
| GB201211247D0 (en) | Improved formulation | |
| GB201206178D0 (en) | Formulations | |
| AU345795S (en) | Cigarette | |
| AU345910S (en) | Cigarette |